| Ident. | Authors (with country if any) | Title |
|---|
| 000035 (2020) |
H. Li [République populaire de Chine] ; Y M Wang [République populaire de Chine] ; J Y Xu [République populaire de Chine] ; B. Cao [République populaire de Chine] | [Potential antiviral therapeutics for 2019 Novel Coronavirus]. |
| 000075 (2020) |
Tuan M. Nguyen [États-Unis] ; Yang Zhang [États-Unis] ; Pier Paolo Pandolfi [États-Unis] | Virus against virus: a potential treatment for 2019-nCov (SARS-CoV-2) and other RNA viruses. |
| 000091 (2020) |
Erwan Sallard [France] ; François-Xavier Lescure [France] ; Yazdan Yazdanpanah [France] ; France Mentre [France] ; Nathan Peiffer-Smadja [France] | Type 1 interferons as a potential treatment against COVID-19 |
| 000102 (2020) |
Alfonso J. Rodriguez-Morales [Colombie] ; Andrea Gabriela Rodriguez-Morales [Chili] ; Claudio A. Méndez [Chili] ; Sebastián Hernández-Botero | Tracing New Clinical Manifestations in Patients with COVID-19 in Chile and Its Potential Relationship with the SARS-CoV-2 Divergence |
| 000129 (2020) |
Yan-Chao Li [République populaire de Chine] ; Wan-Zhu Bai [République populaire de Chine] ; Tsutomu Hashikawa [Japon] | The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. |
| 000158 (2020) |
Peter J. Hotez ; Maria Elena Bottazzi ; David B. Corry | The Potential Role of Th17 Immune Responses in Coronavirus Immunopathology and Vaccine-induced Immune Enhancement |
| 000177 (2020) |
Liang Chen [République populaire de Chine] ; Xiangjie Li [République populaire de Chine] ; Mingquan Chen [République populaire de Chine] ; Yi Feng [République populaire de Chine] ; Chenglong Xiong [République populaire de Chine] | The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. |
| 000189 (2020) |
Yixian Liao [République populaire de Chine] ; Yilu Ye [République populaire de Chine] ; Sumei Li [République populaire de Chine] ; Yilian Zhuang [République populaire de Chine] ; Liye Chen [République populaire de Chine] ; Jianxin Chen [République populaire de Chine] ; Zining Cui [République populaire de Chine] ; Lijian Huo [République populaire de Chine] ; Shuwen Liu [République populaire de Chine] ; Gaopeng Song [République populaire de Chine] | Synthesis and SARs of dopamine derivatives as potential inhibitors of influenza virus PAN endonuclease. |
| 000218 (2020) |
Daniel Batlle [États-Unis] ; Jan Wysocki [États-Unis] ; Karla Satchell [États-Unis] | Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy? |
| 000219 (2020) |
Samuel James Brake [Australie] ; Kathryn Barnsley [Australie] ; Wenying Lu [Australie] ; Kielan Darcy Mcalinden [Australie] ; Mathew Suji Eapen [Australie] ; Sukhwinder Singh Sohal [Australie] | Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19). |
| 000298 (2020) |
Min Jin ; Qiaoxia Tong | Rhabdomyolysis as Potential Late Complication Associated with COVID-19. |
| 000376 (2020) |
Syed Faraz Ahmed ; Ahmed A. Quadeer ; Matthew R. Mckay [République populaire de Chine] | Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies |
| 000388 (2020) |
Qing-Xia Ma [République populaire de Chine] ; Hu Shan [République populaire de Chine] ; Hong-Liang Zhang [République populaire de Chine] ; Gui-Mei Li [République populaire de Chine] ; Rui-Mei Yang [République populaire de Chine] ; Ji-Ming Chen [République populaire de Chine] | Potential utilities of mask-wearing and instant hand hygiene for fighting SARS-CoV-2. |
| 000389 (2020) |
Giorgio Guzzetta [Italie] ; Piero Poletti [Italie] ; Marco Ajelli [Italie] ; Filippo Trentini [Italie] ; Valentina Marziano [Italie] ; Danilo Cereda [Italie] ; Marcello Tirani [Italie] ; Giulio Diurno [Italie] ; Annalisa Bodina [Italie] ; Antonio Barone [Italie] ; Lucia Crottogini [Italie] ; Maria Gramegna [Italie] ; Alessia Melegaro ; Stefano Merler | Potential short-term outcome of an uncontrolled COVID-19 epidemic in Lombardy, Italy, February to March 2020. |
| 000390 (2020) |
Helen C. Johnson [Suède] ; Céline M. Gossner [Suède] ; Edoardo Colzani [Suède] ; John Kinsman [Suède] ; Leonidas Alexakis [Suède] ; Julien Beauté [Suède] ; Andrea Würz [Suède] ; Svetla Tsolova [Suède] ; Nick Bundle [Suède] ; Karl Ekdahl [Suède] | Potential scenarios for the progression of a COVID-19 epidemic in the European Union and the European Economic Area, March 2020 |
| 000391 (2020) |
Lei Zhang [République populaire de Chine] ; Yunhui Liu [République populaire de Chine] | Potential interventions for novel coronavirus in China: A systematic review. |
| 000392 (2020) |
Isaac I. Bogoch [Canada] ; Alexander Watts [Canada] ; Andrea Thomas-Bachli [Canada] ; Carmen Huber [Canada] ; Moritz U G. Kraemer [Royaume-Uni] ; Kamran Khan [Canada] | Potential for global spread of a novel coronavirus from China. |
| 000393 (2020) |
Wen-Hsiang Chen [États-Unis] ; Peter J. Hotez [États-Unis] ; Maria Elena Bottazzi [États-Unis] | Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19. |
| 000394 (2020) |
Yang Pan [République populaire de Chine] ; Luyao Long [République populaire de Chine] ; Daitao Zhang [République populaire de Chine] ; Tingting Yan [République populaire de Chine] ; Shujuan Cui [République populaire de Chine] ; Peng Yang [République populaire de Chine] ; Quanyi Wang [République populaire de Chine] ; Simei Ren [République populaire de Chine] | Potential false-negative nucleic acid testing results for Severe Acute Respiratory Syndrome Coronavirus 2 from thermal inactivation of samples with low viral loads. |
| 000395 (2020) |
Ali Rismanbaf [Iran] | Potential Treatments for COVID-19; a Narrative Literature Review. |
| 000396 (2020) |
Junxiong Pang [Singapour] ; Min Xian Wang [Singapour] ; Ian Yi Han Ang ; Sharon Hui Xuan Tan ; Ruth Frances Lewis ; Jacinta I-Pei Chen ; Ramona A. Gutierrez ; Sylvia Xiao Wei Gwee [Singapour] ; Pearleen Ee Yong Chua [Singapour] ; Qian Yang ; Xian Yi Ng ; Rowena K. S. Yap ; Hao Yi Tan ; Yik Ying Teo ; Chorh Chuan Tan ; Alex R. Cook ; Jason Chin-Huat Yap ; Li Yang Hsu | Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review |
| 000397 (2020) |
Zhen-Dong Tong ; An Tang ; Ke-Feng Li ; Peng Li ; Hong-Ling Wang ; Jing-Ping Yi ; Yong-Li Zhang ; Jian-Bo Yan | Potential Presymptomatic Transmission of SARS-CoV-2, Zhejiang Province, China, 2020. |
| 000398 (2020) |
David A. Schwartz [États-Unis] ; Ashley L. Graham | Potential Maternal and Infant Outcomes from Coronavirus 2019-nCoV (SARS-CoV-2) Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections |
| 000399 (2020) |
Zhong Sun ; Karuppiah Thilakavathy ; S. Suresh Kumar [Malaisie] ; Guozhong He [République populaire de Chine] ; Shi V. Liu [États-Unis] | Potential Factors Influencing Repeated SARS Outbreaks in China |
| 000410 (2020) |
Isaac I. Bogoch [Canada] ; Alexander Watts [Canada] ; Andrea Thomas-Bachli [Canada] ; Carmen Huber [Canada] ; Moritz U G. Kraemer [Royaume-Uni] ; Kamran Khan [Canada] | Pneumonia of unknown aetiology in Wuhan, China: potential for international spread via commercial air travel. |
| 000418 (2020) |
Balamurugan Shanmugaraj [Thaïlande] ; Konlavat Siriwattananon [Thaïlande] ; Kittikhun Wangkanont [Thaïlande] ; Waranyoo Phoolcharoen [Thaïlande] | Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19). |
| 000440 (2020) |
Joseph T. Wu [République populaire de Chine] ; Kathy Leung [République populaire de Chine] ; Gabriel M. Leung [République populaire de Chine] | Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study |
| 000483 (2020) |
Tony Y. Zhang [République populaire de Chine] ; Boyu Zhong [République populaire de Chine] | Meeting the Potential Emergency Global Drug Supply Challenge of Hydroxychloroquine for COVID-19. |
| 000552 (2020) |
Amin Gasmi [France] ; Sadaf Noor [Pakistan] ; Torsak Tippairote [Thaïlande] ; Maryam Dadar [Iran] ; Alain Menzel [France] ; Geir Bj Rklund [Norvège] | Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic |
| 000567 (2020) |
Eakachai Prompetchara [Thaïlande] ; Chutitorn Ketloy [Thaïlande] ; Tanapat Palaga [Thaïlande] | Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. |
| 000573 (2020) |
Tianyi Qiu [République populaire de Chine] ; Tiantian Mao [République populaire de Chine] ; Yuan Wang [République populaire de Chine] ; Mengdi Zhou [République populaire de Chine] ; Jingxuan Qiu [République populaire de Chine] ; Jianwei Wang [République populaire de Chine] ; Jianqing Xu [République populaire de Chine] ; Zhiwei Cao [République populaire de Chine] | Identification of potential cross-protective epitope between a new type of coronavirus (2019-nCoV) and severe acute respiratory syndrome virus. |
| 000577 (2020) |
Marina Macchiagodena ; Marco Pagliai ; Piero Procacci | Identification of Potential Binders of the Main Protease 3CLpro of the COVID-19 via Structure-Based Ligand Design and Molecular Modeling |
| 000580 (2020) |
Ling Lin [République populaire de Chine] ; Lianfeng Lu [République populaire de Chine] ; Wei Cao [République populaire de Chine] ; Taisheng Li [République populaire de Chine] | Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia. |
| 000624 (2020) |
Mohamed E. El Zowalaty [Suède, États-Unis, Émirats arabes unis] ; Josef D. J Rhult [Suède] | From SARS to COVID-19: A previously unknown SARS-CoV-2 virus of pandemic potential infecting humans – Call for a One Health approach |
| 000651 (2020) |
Xingguang Li [République populaire de Chine] ; Junjie Zai [République populaire de Chine] ; Qiang Zhao [République populaire de Chine] ; Qing Nie [République populaire de Chine] ; Yi Li [République populaire de Chine] ; Brian T. Foley [États-Unis] ; Antoine Chaillon [États-Unis] | Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2. |
| 000747 (2020) |
Md Insiat Islam Rabby [Malaisie] | Current Drugs with Potential for Treatment of COVID-19: A Literature Review. |
| 000783 (2020) |
Junyi Guo ; Zheng Huang ; Li Lin ; Jiagao Lv | Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection. |
| 000799 (2020) |
Miguel Angel Martinez [Espagne] | Compounds with therapeutic potential against novel respiratory 2019 coronavirus. |
| 000832 (2020) |
Huijun Chen [République populaire de Chine] ; Juanjuan Guo [République populaire de Chine] ; Chen Wang [République populaire de Chine] ; Fan Luo [République populaire de Chine] ; Xuechen Yu [République populaire de Chine] ; Wei Zhang [États-Unis] ; Jiafu Li [République populaire de Chine] ; Dongchi Zhao [République populaire de Chine] ; Dan Xu [République populaire de Chine] ; Qing Gong [République populaire de Chine] ; Jing Liao [République populaire de Chine] ; Huixia Yang [République populaire de Chine] ; Wei Hou [République populaire de Chine] ; Yuanzhen Zhang [République populaire de Chine] | Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records |
| 000838 (2020) |
Erlina Burhan [Indonésie] ; Prasenohadi Prasenohadi ; Rita Rogayah ; Fathiyah Isbaniyah ; Tina Reisa ; Ibrahim Dharmawan | Clinical Progression of COVID-19 Patient with Extended Incubation Period, Delayed RT-PCR Time-to-positivity, and Potential Role of Chest CT-scan. |
| 000854 (2020) |
Yi Xu [République populaire de Chine] ; Xufang Li [République populaire de Chine] ; Bing Zhu [République populaire de Chine] ; Huiying Liang [République populaire de Chine] ; Chunxiao Fang [République populaire de Chine] ; Yu Gong [République populaire de Chine] ; Qiaozhi Guo [République populaire de Chine] ; Xin Sun [République populaire de Chine] ; Danyang Zhao [République populaire de Chine] ; Jun Shen [République populaire de Chine] ; Huayan Zhang [République populaire de Chine, États-Unis] ; Hongsheng Liu [République populaire de Chine] ; Huimin Xia [République populaire de Chine] ; Jinling Tang [République populaire de Chine] ; Kang Zhang [République populaire de Chine] ; Sitang Gong [République populaire de Chine] | Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding |
| 000893 (2020) |
Katarzyna Kotfis ; Karolina Skonieczna- Ydecka | COVID-19: gastrointestinal symptoms and potential sources of 2019-nCoV transmission. |
| 000897 (2020) |
Rui Zhang [République populaire de Chine] ; Xuebin Wang [République populaire de Chine] ; Leng Ni [République populaire de Chine] ; Xiao Di [République populaire de Chine] ; Baitao Ma [République populaire de Chine] ; Shuai Niu [République populaire de Chine] ; Changwei Liu [République populaire de Chine] ; Russel J. Reiter [États-Unis] | COVID-19: Melatonin as a potential adjuvant treatment. |
| 000931 (2020) |
Deepak Atri [États-Unis] ; Hasan K. Siddiqi [États-Unis] ; Joshua Lang [États-Unis] ; Victor Nauffal [États-Unis] ; David A. Morrow [États-Unis] ; Erin A. Bohula [États-Unis] | COVID-19 for the Cardiologist: A Current Review of the Virology, Clinical Epidemiology, Cardiac and Other Clinical Manifestations and Potential Therapeutic Strategies. |
| 000963 (2020) |
Jimin Xu ; Pei-Yong Shi [États-Unis] ; Hongmin Li [États-Unis] ; Jia Zhou [États-Unis] | Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic
Potential |
| 000982 (2020) |
Emily A. Troyer [États-Unis] ; Jordan N. Kohn [États-Unis] ; Suzi Hong [États-Unis] | Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms☆ |
| 000993 (2020) |
Haibo Zhang [République populaire de Chine, Canada] ; Josef M. Penninger [Autriche] ; Yimin Li [République populaire de Chine] ; Nanshan Zhong [République populaire de Chine] ; Arthur S. Slutsky [Canada, République populaire de Chine] | Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target |
| 000997 (2020) |
Canrong Wu [République populaire de Chine] ; Yang Liu [République populaire de Chine] ; Yueying Yang [République populaire de Chine] ; Peng Zhang [République populaire de Chine] ; Wu Zhong [République populaire de Chine] ; Yali Wang [République populaire de Chine] ; Qiqi Wang [République populaire de Chine] ; Yang Xu [République populaire de Chine] ; Mingxue Li [République populaire de Chine] ; Xingzhou Li [République populaire de Chine] ; Mengzhu Zheng [République populaire de Chine] ; Lixia Chen [République populaire de Chine] ; Hua Li [République populaire de Chine] | Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods |
| 000A27 (2020) |
Christian Ja Sigrist ; Alan Bridge ; Philippe Le Mercier | A potential role for integrins in host cell entry by SARS-CoV-2 |
| 000A57 (2020) |
T M Wassenaar [Allemagne] ; Y. Zou [République populaire de Chine] | 2019_nCoV/SARS-CoV-2: rapid classification of betacoronaviruses and identification of Traditional Chinese Medicine as potential origin of zoonotic coronaviruses. |
| 000A87 (2007) |
Jan Balzarini [Belgique] | Carbohydrate-binding agents: a potential future cornerstone for the chemotherapy of enveloped viruses? |
